Cengiz Dibekoğlu (C Dibekoğlu)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

End Stage Renal Disease

Histone Deacetylase

Patient Reported Outcomes

Top Venues

Acta cirurgica brasileira

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

This page only lists publications with an associated author ORCID identifier.

Publications

Cengiz Dibekoğlu, Yigit Uyanikgil, Oytun Erbaş
Sulfasalazine prevents lung injury due to intra-abdominal sepsis in rats: possible role of Nrf2 and angiopoietin-2. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 56 (2023)
Cengiz Dibekoğlu
Does the length matter in acute appendicitis for the perforation risk?: A retrospective cohort study. Medicine 101 (48) (2022)
Cengiz Dibekoğlu, Oytun Erbaş
Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model. Acta cirurgica brasileira 37 (5) (2022)
Cengiz Dibekoğlu
Does the length matter in acute appendicitis for the perforation risk?: A retrospective cohort study. Medicine 101 (48) (2022)
Cengiz Dibekoğlu
Does the length matter in acute appendicitis for the perforation risk?: A retrospective cohort study. Medicine 101 (48) (2022)
Mehmet Fatih Bozkurt, Muhammed Nasir Bhaya, Cengiz Dibekoğlu, Ayberk Akat, Utku Ateş, Oytun Erbaş
Mesenchymal stem cells have ameliorative effect on the colitis model via Nrf2/HO-1 pathway. Acta cirurgica brasileira 37 (7) (2022)
Cengiz Dibekoğlu
Does the length matter in acute appendicitis for the perforation risk?: A retrospective cohort study. Medicine 101 (48) (2022)
Cengiz Dibekoğlu
Does the length matter in acute appendicitis for the perforation risk?: A retrospective cohort study. Medicine 101 (48) (2022)